272 related articles for article (PubMed ID: 19250200)
1. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.
Santen R; Cavalieri E; Rogan E; Russo J; Guttenplan J; Ingle J; Yue W
Ann N Y Acad Sci; 2009 Feb; 1155():132-40. PubMed ID: 19250200
[TBL] [Abstract][Full Text] [Related]
2. Estrogen metabolites and breast cancer.
Santen RJ; Yue W; Wang JP
Steroids; 2015 Jul; 99(Pt A):61-6. PubMed ID: 25168343
[TBL] [Abstract][Full Text] [Related]
3. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.
Yue W; Santen RJ; Wang JP; Li Y; Verderame MF; Bocchinfuso WP; Korach KS; Devanesan P; Todorovic R; Rogan EG; Cavalieri EL
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):477-86. PubMed ID: 14623547
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen versus aromatase inhibitors for breast cancer prevention.
Yue W; Wang JP; Li Y; Bocchinfuso WP; Korach KS; Devanesan PD; Rogan E; Cavalieri E; Santen RJ
Clin Cancer Res; 2005 Jan; 11(2 Pt 2):925s-30s. PubMed ID: 15701888
[TBL] [Abstract][Full Text] [Related]
5. Estrogenic regulation of host immunity against an estrogen receptor-negative human breast cancer.
Curran EM; Judy BM; Duru NA; Wang HQ; Vergara LA; Lubahn DB; Estes DM
Clin Cancer Res; 2006 Oct; 12(19):5641-7. PubMed ID: 17000652
[TBL] [Abstract][Full Text] [Related]
6. Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment.
Santen RJ; Song RX; Zhang Z; Kumar R; Jeng MH; Masamura S; Lawrence J; MacMahon LP; Yue W; Berstein L
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):155-65. PubMed ID: 16024245
[TBL] [Abstract][Full Text] [Related]
7. Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF-7 breast cancer cells by a C17alpha-alkynylestradiol-porphyrin conjugate.
Swamy N; Purohit A; Fernandez-Gacio A; Jones GB; Ray R
J Cell Biochem; 2006 Oct; 99(3):966-77. PubMed ID: 16741968
[TBL] [Abstract][Full Text] [Related]
8. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer.
Barnett DH; Sheng S; Charn TH; Waheed A; Sly WS; Lin CY; Liu ET; Katzenellenbogen BS
Cancer Res; 2008 May; 68(9):3505-15. PubMed ID: 18451179
[TBL] [Abstract][Full Text] [Related]
10. Detection of DNA strand breaks and oxidized DNA bases at the single-cell level resulting from exposure to estradiol and hydroxylated metabolites.
Rajapakse N; Butterworth M; Kortenkamp A
Environ Mol Mutagen; 2005 May; 45(4):397-404. PubMed ID: 15662657
[TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 down-regulation activates estrogen receptor alpha expression and leads to 17beta-estradiol-stimulated mammary tumorigenesis.
Zhang X; Shen P; Coleman M; Zou W; Loggie BW; Smith LM; Wang Z
Anticancer Res; 2005; 25(1A):369-75. PubMed ID: 15816560
[TBL] [Abstract][Full Text] [Related]
12. Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis.
Harrell JC; Dye WW; Harvell DM; Pinto M; Jedlicka P; Sartorius CA; Horwitz KB
Cancer Res; 2007 Nov; 67(21):10582-91. PubMed ID: 17975003
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal.
Lewis JS; Osipo C; Meeke K; Jordan VC
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):131-41. PubMed ID: 15862958
[TBL] [Abstract][Full Text] [Related]
14. The breast cancer cells response to chronic hypoxia involves the opposite regulation of NF-kB and estrogen receptor signaling.
Scherbakov AM; Lobanova YS; Shatskaya VA; Krasil'nikov MA
Steroids; 2009 Jun; 74(6):535-42. PubMed ID: 19428442
[TBL] [Abstract][Full Text] [Related]
15. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
[TBL] [Abstract][Full Text] [Related]
16. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.
Ho SM; Leung YK; Chung I
Ann N Y Acad Sci; 2006 Nov; 1089():177-93. PubMed ID: 17261766
[TBL] [Abstract][Full Text] [Related]
17. SiRNA inhibition of ER-alpha expression reduces KGF-induced proliferation of breast cancer cells.
Zang XP; Pento JT
Anticancer Res; 2008; 28(5A):2733-5. PubMed ID: 19035303
[TBL] [Abstract][Full Text] [Related]
18. 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells.
Russo J; Fernandez SV; Russo PA; Fernbaugh R; Sheriff FS; Lareef HM; Garber J; Russo IH
FASEB J; 2006 Aug; 20(10):1622-34. PubMed ID: 16873885
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.
Peters AA; Buchanan G; Ricciardelli C; Bianco-Miotto T; Centenera MM; Harris JM; Jindal S; Segara D; Jia L; Moore NL; Henshall SM; Birrell SN; Coetzee GA; Sutherland RL; Butler LM; Tilley WD
Cancer Res; 2009 Aug; 69(15):6131-40. PubMed ID: 19638585
[TBL] [Abstract][Full Text] [Related]
20. A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions.
Fuqua SA; Wiltschke C; Zhang QX; Borg A; Castles CG; Friedrichs WE; Hopp T; Hilsenbeck S; Mohsin S; O'Connell P; Allred DC
Cancer Res; 2000 Aug; 60(15):4026-9. PubMed ID: 10945602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
